D.E. Shaw & Co
HPTX

D.E. Shaw & Co’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

D.E. Shaw & Co’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-176,831
Closed -$8.12M – 4042
2015
Q1 		$8.12M Buy
176,831
+6,104
+4% +$183K 0.01% 1085
2014
Q4 		$4.1M Buy
170,727
+75,296
+79% +$1.7M 0.01% 1718
2014
Q3 		$2.41M Buy
95,431
+41,399
+77% +$1.03M ﹤0.01% 2096
2014
Q2 		$1.41M Buy
54,032
+20,812
+63% +$535K ﹤0.01% 2616
2014
Q1 		$857K Buy
+33,220
New +$900K ﹤0.01% 3165

D.E. Shaw & Co's HPTX Position: Q2 2015 in Review

D.E. Shaw & Co sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 176,831 shares — an estimated $8.12M sold.

D.E. Shaw & Co first reported a position in HPTX in Q1 2014 and held it in 5 quarters. The position peaked at $8.12M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • D.E. Shaw & Co reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 176,831 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $8.12M.
  • D.E. Shaw & Co first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • D.E. Shaw & Co's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $8.12M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.